Clinical practice guideline for #NephJC?
What do people think about this? Is this appropriate for journal club or is this akin to doing a review article?
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.
Why does the CKD screening matters? Because of this: http://t.co/HKuUTJgZvR @NephJC #nephJC
— Xavier F. Vela (@xaviervel) May 6, 2014
Though not a tradition subject for journal club, it seems that clinical practice guidelines have an important role in today’s practice (1/2)
— Joel Topf (@kidney_boy) May 5, 2014
I propose the new hyponatremia guidelines for #NephJC http://t.co/hNGxibmNfy (2/2)
— Joel Topf (@kidney_boy) May 5, 2014
What do people think about this? Is this appropriate for journal club or is this akin to doing a review article?
Chronic kidney disease blast Central America: http://t.co/7Yxkf8uMfb #renalweek #kidneyweek #NephJC pic.twitter.com/4XyXCbkzma
— Xavier F. Vela (@xaviervel) May 1, 2014
Latest hope for DN: endothelin antagonists http://t.co/64hQ0rs5xX one for #NephJC? @NephJC @kidney_boy
— Paul Phelan (@paulphel) April 23, 2014
http://t.co/siLrMR1v7i Time for routine kidney biopsy in all patients (not just the risk ones) with suspected GN? Paper for #NephJC ?
— ChristosArgyropoulos (@ChristosArgyrop) April 23, 2014
Prenatal risk factors for childhood CKD in JASN -- a possible peg article for #NephJC? http://t.co/t7hmG91XXS
— NatureRevNephrology (@NatRevNeph) April 25, 2014
Atrasentan lowers residual albuminuria T2DM, but ... "manageable" fluid-overload. #NephJC #CJASN http://t.co/G5C6FT5PSu
— Ernesto LopezAlmaraz (@kidney_doctor) April 29, 2014